David Pernock
2011 - Fibrocell Science
In 2011, David Pernock earned a total compensation of $1.9M as Chief Executive Officer at Fibrocell Science, a 23% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,464,495 |
|---|---|
| Salary | $450,000 |
| Total | $1,914,495 |
Pernock received $1.5M in option awards, accounting for 76% of the total pay in 2011.
Pernock also received $450K in salary.
Rankings
In 2011, David Pernock's compensation ranked 3,445th out of 10,747 executives tracked by ExecPay. In other words, Pernock earned more than 67.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,445 out of 10,747 | 68th |
Division Manufacturing | 1,199 out of 3,960 | 70th |
Major group Chemicals And Allied Products | 234 out of 1,038 | 78th |
Industry group Drugs | 131 out of 786 | 83rd |
Industry Pharmaceutical Preparations | 109 out of 571 | 81st |
Source: SEC filing on May 31, 2013.
Pernock's colleagues
We found three more compensation records of executives who worked with David Pernock at Fibrocell Science in 2011.
News
Eagle Pharmaceuticals CEO Scott Tarriff's 2021 pay falls 32% to $6.5M
June 15, 2022
Eagle Pharmaceuticals CEO Scott Tarriff's 2020 pay rises 20% to $9.5M
April 30, 2021
Eagle Pharmaceuticals CEO Scott Tarriff's 2019 pay falls 30% to $7.9M
April 29, 2020
Eagle Pharmaceuticals CEO Scott Tarriff's 2018 pay jumps 41% to $11M
April 30, 2019